semaglutide patent novo nordisk New Delhi, March 20, 2026 – The primary protecting semaglutide, the powerhouse ingredient in Nordisk's globally renowned Ozempic and Wegovy, officially expired in India on Friday, March 20, 2026. This Article » ProAct
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9


























